Item 7.01 Regulation FD Disclosure.

On January 11, 2021, Microbot Medical Inc. issued a press release announcing that it has concluded 2020 with the achievement of several operating and developmental milestones, with plans to execute additional developmental, regulatory and clinical goals in 2021 as specified in the press release.

The press release furnished as Exhibit 99.1 to this Current Report on Form 8-K is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

© Edgar Online, source Glimpses